As of 2025-12-16, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 14.6x | 14.0x |
| Forward P/E multiples | 13.3x - 22.6x | 17.8x |
| Fair Price | (15.80) - (17.02) | (18.37) |
| Upside | -183.2% - -189.6% | -196.7% |
| Date | EV/EBITDA |